Does Medicare Cover Isturisa? Part D, Pricing, and Appeals

Medicare Part D can cover Isturisa (osilodrostat), but coverage depends on your specific plan’s formulary and almost always comes with prior authorization and step-therapy requirements. The practical cost news is better than the drug’s six-figure price tag suggests: for 2026, federal law caps what any Medicare Part D enrollee pays out of pocket for covered drugs at $2,100 for the whole year.

Which Part D Plans Actually List It

Isturisa is an oral medication dispensed through specialty pharmacies, which places it under Part D rather than Part B. Whether your plan pays depends on its formulary.

Some plans do cover it. Humana’s 2025 Premier Rx and Value Rx plans, for example, include Isturisa on Tier 5, the specialty tier, with prior authorization and specialty pharmacy dispensing required.1Counterforce Health. How to Get Isturisa Covered by Humana in Georgia Other plans leave it off entirely. Health Alliance listed Isturisa as a deletion from its 2025 HMO formulary.2Health Alliance. 2025 Medicare Formulary Before you assume anything, pull your plan’s current formulary or call member services directly and ask whether osilodrostat is covered, on what tier, and under what restrictions.

Prior Authorization and Step Therapy

Even when a plan covers Isturisa, filling the prescription is not routine. Plans universally require prior authorization. Your prescriber has to document that you meet the clinical criteria before the plan will pay. Typical requirements across insurers include:

  • A confirmed diagnosis of endogenous Cushing’s syndrome or Cushing’s disease.
  • Patient age 18 or older.
  • Documentation that you are not a candidate for pituitary surgery, or that surgery was attempted and was not curative.
  • The prescription written by, or in consultation with, an endocrinologist.3Health Net. Osilodrostat Clinical Policy

Many plans also impose step therapy, meaning you have to try and fail a cheaper alternative first. Common prerequisites include pasireotide (Signifor), generic ketoconazole, generic cabergoline, metyrapone (Metopirone), and mitotane (Lysodren).4Blue Cross and Blue Shield of Louisiana. Osilodrostat Coverage Policy Molina Healthcare’s policy, updated in October 2025, specifically requires a 12-week trial and failure (or contraindication) of ketoconazole plus documented baseline labs before Isturisa is approved.5Molina Healthcare. Isturisa Coverage Policy Step-therapy requirements can be waived if your prescriber supplies clinical evidence that the alternatives would be ineffective or cause adverse reactions.

Specialty Pharmacy Dispensing

You can’t pick Isturisa up at a retail pharmacy. All prescriptions move through a limited specialty pharmacy network. Recordati’s designated specialty pharmacy is Anovo Specialty Rx, and prescribers must submit a Patient Prescription Form to start the process.6Isturisa.com. HCP Resources and Support Some Medicare plans route prescriptions through their own preferred specialty pharmacies, such as CVS Specialty or Accredo. The specialty pharmacy usually handles prior authorization on your behalf, but the process can take two to four weeks.7GoodRx. Isturisa The medication is then mailed to you.

What You’ll Actually Pay in 2026

The Inflation Reduction Act reshaped the math for expensive specialty drugs under Part D. For 2026, total annual out-of-pocket spending on covered Part D drugs is capped at $2,100.8Medicare.gov. Part D Costs The benefit still moves through phases:

  • Deductible phase: you pay the full cost of prescriptions until you meet your plan’s deductible, which can be up to $615 in 2026.
  • Initial coverage phase: after the deductible, you pay 25% coinsurance. For a drug priced like Isturisa, this phase is extremely short. The first fill alone can push you past the out-of-pocket threshold.
  • Catastrophic phase: once your out-of-pocket spending hits $2,100, you pay $0 for covered Part D drugs for the rest of the year.8Medicare.gov. Part D Costs

For an Isturisa patient, the practical effect is reaching the $2,100 cap very early in the year, likely at the first fill, and paying nothing for the drug after that. Before the Inflation Reduction Act, patients on high-cost specialty drugs could face annual out-of-pocket costs of $5,000 to $6,000 or more.9KFF. Explaining the Prescription Drug Provisions in the Inflation Reduction Act

Spreading the Cost Across the Year

Paying $2,100 at the pharmacy counter in January is still a hard hit. The Medicare Prescription Payment Plan lets you spread that out-of-pocket amount into monthly installments. Every Part D plan has to offer it, there is no cost to join, and you can enroll at any time by calling your plan.10Medicare.gov. Medicare Prescription Payment Plan Instead of paying the pharmacy, you receive a monthly bill from the plan. For someone enrolling in January, the first month’s payment could be as low as $175, with the rest spread across the remaining months.11National Center for Biotechnology Information. Impact of IRA Provisions on Part D Specialty Drug Costs The plan doesn’t reduce your total costs; it only reshapes when you pay them.12Medicare.gov. What’s the Medicare Prescription Payment Plan

If Your Plan Denies Coverage

Denials happen for several reasons: the drug isn’t on the formulary, the prior authorization paperwork is rejected, or step-therapy requirements weren’t met. You have a structured path to challenge any of these.

Requesting a Formulary Exception

The first move is to ask the plan for a coverage exception. Your prescriber submits a supporting statement explaining why Isturisa is medically necessary: that formulary alternatives have been tried and failed, caused adverse effects, or are expected to be less effective for you.13CMS. Part D Exceptions The statement can be verbal or written, on the plan’s form, CMS’s model form, or a plain letter. The plan must respond within 72 hours for a standard request, or 24 hours if your prescriber certifies that a delay could seriously harm your health.14Medicare Interactive. Introduction to Part D Appeals

The Appeals Ladder

If the exception is denied, you can escalate:

  • Level 1, Redetermination: filed with the plan within 60 to 65 days of the denial. The plan must decide within 7 days, or 72 hours if expedited.
  • Level 2, Independent Review Entity: if the plan upholds its denial, you have 60 days to appeal to an outside reviewer, with the same response deadlines.
  • Level 3, Administrative Law Judge: available if the amount in controversy meets a minimum threshold ($200 in 2026), heard through the Office of Medicare Hearings and Appeals.
  • Level 4, Medicare Appeals Council: a further review if the ALJ ruling is unfavorable.
  • Level 5, Federal District Court: the final option, available when the amount in controversy reaches $1,960 in 2026.14Medicare Interactive. Introduction to Part D Appeals

If you win at any level, the plan should cover the drug through the end of the calendar year. Keep copies of everything and write down every call.15Medicare.gov. Drug Plan Appeals

Help Paying for Isturisa on Medicare

One important boundary first. Recordati’s R.A.R.E. (Recordati Access, Resources, and Engagement) program offers a $20 copay card, but that benefit is limited to patients with commercial insurance. Medicare beneficiaries are not eligible for the copay card.16Isturisa.com. Patient Support The R.A.R.E. program does still offer non-financial support regardless of insurance type, including help with prior authorizations, appeals, nurse educators, and specialty pharmacy coordination. Recordati also runs a separate Patient Assistance Program that may provide free or reduced-cost medication to qualifying patients, though eligibility details for Medicare beneficiaries aren’t publicly listed.17RxAssist. Recordati Rare Diseases Patient Support Program

Independent Charitable Foundations

Because federal rules keep manufacturer copay cards away from Medicare patients, independent foundations fill the gap:

  • PAN Foundation offers grants of up to $11,600 per year for patients with Cushing’s disease or syndrome, with Isturisa among the qualifying medications. Income must be at or below 500% of the Federal Poverty Level, and you must have insurance that covers the drug.18PAN Foundation. Cushing’s Disease or Syndrome Fund
  • HealthWell Foundation provides up to $10,000 per year for Cushing’s disease or syndrome and explicitly covers Medicare, Medicaid, and commercial insurance. The program is needs-based and requires proof of diagnosis.19PrescriberPoint. HealthWell Foundation Cushing’s Disease or Cushing’s Syndrome
  • NORD (National Organization for Rare Disorders) operates RareCare Patient Assistance Programs for Cushing’s syndrome that can help with copays, premiums, and medication costs.20CSRF. Financial Assistance

These disease-specific funds sometimes close when funding runs out, so timing matters. The PAN Foundation’s FundFinder tool tracks assistance funds across nine charitable organizations and can help you identify programs currently open to new enrollment.

Extra Help (Low-Income Subsidy)

If your income is limited, the Extra Help program can carry most of the Part D cost for you. For 2026, Extra Help eliminates plan premiums and deductibles, caps copays at $5.10 for generics and $12.65 for brand-name drugs, and counts toward the $2,100 out-of-pocket cap. Once total drug costs (including payments made through Extra Help) hit $2,100, you pay $0. You qualify automatically if you receive full Medicaid, Supplemental Security Income, or help from a state Medicare Savings Program. Otherwise, you may qualify if income is below $23,940 (individual) or $32,460 (married couple) and your resources are below the applicable limits.21Medicare.gov. Get Help With Drug Costs You can apply any time through the Social Security Administration.22Social Security Administration. Part D Extra Help